Lipomatosen.

Area of Science:

• Medical Science
• Dermatology
• Pathology

Background:

• Lipomatoses are benign, often symmetrical, fatty tissue proliferations lacking a fibrous capsule, unlike circumscribed lipomas.
• Benign symmetrical lipomatosis (BSL), also known as Launois-Bensaude syndrome, is the most common type, with four subtypes based on fat distribution.
• The etiology and pathogenesis remain largely unknown, with potential links to heredity, alcohol consumption, and mitochondrial dysfunction.

Purpose of the Study:

• To provide a comprehensive overview of lipomatoses, including benign symmetrical lipomatosis (BSL) and lipomatosis dolorosa.
• To discuss the differential diagnoses, comorbidities, and current therapeutic approaches for these conditions.
• To highlight the challenges in treatment and the outcomes of existing interventions.

Main Methods:

• Literature review and synthesis of existing research on lipomatoses.
• Analysis of clinical presentations, diagnostic criteria, and epidemiological data.
• Evaluation of therapeutic strategies, including medical and surgical options.

Main Results:

• Lipomatoses can occur in isolation or with comorbidities; effective drug therapies are currently unknown.
• Surgical procedures can offer symptomatic relief for lipomatoses, although recurrence is possible.
• Lipomatosis dolorosa, primarily affecting middle-aged women, is characterized by painful fatty tissue proliferation and requires careful differential diagnosis, including depression.

Conclusions:

• Lipomatoses encompass a group of benign fatty tissue disorders with varied presentations and unknown etiologies.
• Current treatment focuses on symptomatic management, with surgery offering potential relief but not always a permanent solution.
• Further research is needed to elucidate the pathogenesis and develop evidence-based therapies for lipomatoses.